Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 08/01/16

Staff, Pictures and Bios

Vikram Devgan, Ph.D., MBA, Branch Chief, CGCB

Vikram Devgan, Ph.D., MBA. joined the National Cancer Institute in 2016 as a Chief of Clinical Grants and Contracts Branch of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis. From 2006 to 2016, Dr. Devgan held positions of increasing responsibilities with QIAGEN Inc., rising to Head of the Center of Excellence for Biological Research Content. More…

William D. Merritt, PhD, Program Director

Dr. Merritt joined CGCB/CTEP as a Program Director in January, 2006, where his major focus has been to manage a large portfolio of clinical grants in the areas of stem cell transplant and immunotherapeutic and drug therapies for hematologic malignancies. In this position he has also been active in the management of the Cancer Immunotherapy Trials Network More…

Minkyung (Min) Song, Ph.D., Program Director

Dr. Song fosters, manages, oversees and analyzes the NCI portfolio on multidisciplinary, translational and clinical research grants and cooperative agreements for Clinical trials of chemotherapy, immunotherapy, cellular therapy, gene therapy, radiation therapy, surgery, or their combinations, and associated correlative studies. More…

William C. Timmer, PhD, Program Director

Dr. William Timmer joined CGCB as a Program Director (Health Science Administrator) in September 2007. His principal effort is directed toward management of a portfolio of clinical oncology research grants (principally involving brain, head and neck, lung, liver, colorectal, pancreatic and sarcoma cancers) within CTEP. More…

Rolanda Hawkins, Program Specialist

Ms. Rolanda Hawkins has several years of experience in grants, cooperative agreements, and contracts in the administrative and program arena of NCI. Ms. Hawkins joined CTEP in 1990 as a Technical Assistant for grants and contracts and has been working in the Clinical Grants and Contracts Branch (CGCB) since its inception. More…

Kim Witherspoon, Senior Program Specialist, Biologist

Ms. Kim Witherspoon has been a part of the Cancer Therapy Evaluation Program (CTEP) since September 2000. She became part CTEPís Investigational Drug Branch (IDB) in February 2018. In IDB, Kim ensures compliance with NIH and NCI grant policy. She is Senior Program Specialist for the Experimental Therapeutics Clinical Trials Network (ETCTN). She performs duties as a Program Official, a Level II FAC-Contract Officer's Representative (COR), and Program Analyst. As a Program Official, her portfolio includes clinical research projects focused on bioethics. More…

About the Branch Chief

Vikram Devgan, Ph.D., MBA Vikram Devgan, Ph.D., MBA. joined the National Cancer Institute in 2016 as a Chief of Clinical Grants and Contracts Branch of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis. From 2006 to 2016, Dr. Devgan held positions of increasing responsibilities with QIAGEN Inc., rising to Head of the Center of Excellence for Biological Research Content. More…